These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 8161656)

  • 1. Preparation and characterization of albumin-heparin microspheres.
    Cremers HF; Kwon G; Bae YH; Kim SW; Verrijk R; Noteborn HP; Feijen J
    Biomaterials; 1994 Jan; 15(1):38-48. PubMed ID: 8161656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Properties of human albumin microparticles prepared by a chilled cross-linking technique.
    Oner L; Groves MJ
    J Pharm Pharmacol; 1993 Oct; 45(10):866-70. PubMed ID: 7904624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro release of adriamycin from drug-loaded albumin and haemoglobin microspheres.
    Willmott N; Cummings J; Florence AT
    J Microencapsul; 1985; 2(4):293-304. PubMed ID: 3939779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation and characterization of uniform-sized chitosan microspheres containing insulin by membrane emulsification and a two-step solidification process.
    Wang LY; Gu YH; Zhou QZ; Ma GH; Wan YH; Su ZG
    Colloids Surf B Biointerfaces; 2006 Jul; 50(2):126-35. PubMed ID: 16787743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Degradation and intrahepatic compatibility of albumin-heparin conjugate microspheres.
    Cremers HF; Wolf RF; Blaauw EH; Schakenraad JM; Lam KH; Nieuwenhuis P; Verrijk R; Kwon G; Bae YH; Kim SW
    Biomaterials; 1994 Jun; 15(8):577-85. PubMed ID: 7948576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Albumin microspheres as a drug delivery system: relation among turbidity ratio, degree of cross-linking, and drug release.
    Rubino OP; Kowalsky R; Swarbrick J
    Pharm Res; 1993 Jul; 10(7):1059-65. PubMed ID: 8378248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation of uniform sized chitosan microspheres by membrane emulsification technique and application as a carrier of protein drug.
    Wang LY; Ma GH; Su ZG
    J Control Release; 2005 Aug; 106(1-2):62-75. PubMed ID: 15922472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biodegradable heparin-loaded microspheres: carrier molecular composition and microsphere structure.
    Luo X; Qiu D; He B; Wang L; Luo J
    Macromol Biosci; 2006 May; 6(5):373-81. PubMed ID: 16685689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and In Vitro Evaluation of a Novel Drug Delivery System (Albumin Microspheres Containing Liposomes) Applied to Vancomycin.
    de Jesús Valle MJ; López Díaz D; Velázquez Salicio M; Sánchez Navarro A
    J Pharm Sci; 2016 Jul; 105(7):2180-7. PubMed ID: 27290625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regional delivery of microspheres to liver metastases: the effects of particle size and concentration on intrahepatic distribution.
    Anderson JH; Angerson WJ; Willmott N; Kerr DJ; McArdle CS; Cooke TG
    Br J Cancer; 1991 Dec; 64(6):1031-4. PubMed ID: 1764363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation of uniform-sized pH-sensitive quaternized chitosan microsphere by combining membrane emulsification technique and thermal-gelation method.
    Wu J; Wei W; Wang LY; Su ZG; Ma GH
    Colloids Surf B Biointerfaces; 2008 Jun; 63(2):164-75. PubMed ID: 18226510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Albumin microspheres as vehicles for the sustained and controlled release of doxorubicin.
    Jones C; Burton MA; Gray BN
    J Pharm Pharmacol; 1989 Dec; 41(12):813-6. PubMed ID: 2576441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation and characterization of glutaraldehyde cross-linked O-carboxymethylchitosan microspheres for controlled delivery of pazufloxacin mesilate.
    Liu YF; Huang KL; Peng DM; Ding P; Li GY
    Int J Biol Macromol; 2007 Jun; 41(1):87-93. PubMed ID: 17292465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of primary emulsions on microsphere size and protein-loading in the double emulsion process.
    Maa YF; Hsu CC
    J Microencapsul; 1997; 14(2):225-41. PubMed ID: 9132473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of preparation conditions on the monodispersity of albumin microspheres.
    el-Mahdy M; Ibrahim ES; Safwat S; el-Sayed A; Ohshima H; Makino K; Muramatsu N; Kondo T
    J Microencapsul; 1998; 15(5):661-73. PubMed ID: 9743920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Size-controlled and monodisperse enzyme-encapsulated chitosan microspheres developed by the SPG membrane emulsification technique.
    Akamatsu K; Ikeuchi Y; Nakao A; Nakao S
    J Colloid Interface Sci; 2012 Apr; 371(1):46-51. PubMed ID: 22285100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. pH-sensitive release of indomethacin using lactan-acetate microspheres.
    Na K; Lee KY
    Drug Dev Ind Pharm; 1998 Jun; 24(6):563-8. PubMed ID: 9876624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microencapsulation of protein drugs for drug delivery: strategy, preparation, and applications.
    Ma G
    J Control Release; 2014 Nov; 193():324-40. PubMed ID: 25218676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclophosphamide loaded albumin microspheres II. Release characteristics.
    Vural I; Kaş HS; Hincal AA; Cavé G
    J Microencapsul; 1990; 7(4):511-6. PubMed ID: 2125078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation and characterization of a novel pH-sensitive coated microsphere for duodenum-specific drug delivery.
    Zhou D; Zhu X; Wang Y; Jin Y; Xu X; Fan T; Liu Y; Zhang Z; Huang Y
    Arch Pharm Res; 2012 May; 35(5):839-50. PubMed ID: 22644851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.